• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于人工智能的软件工具对多发性硬化症患者脑萎缩进行的真实世界分析。

Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool.

作者信息

Reinhardt Caroline, Angstwurm Klemens, Freudenstein David, Lee De-Hyung, Wendl Christina, Linker Ralf A

机构信息

Department of Neurology, University of Regensburg, Universitätsstr. 84, 93053, Regensburg, Germany.

Department of Neuroradiology, University of Regensburg, Regensburg, Germany.

出版信息

Neurol Res Pract. 2024 Aug 8;6(1):40. doi: 10.1186/s42466-024-00339-y.

DOI:10.1186/s42466-024-00339-y
PMID:39113151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308334/
Abstract

BACKGROUND

Atrophy of white and grey matter volumes occurs early in the brains of people with multiple sclerosis (pwMS) and has great clinical relevance. In clinical trials, brain atrophy can be quantified by magnetic resonance imaging (MRI) with automated software tools.

METHODS

In this study, we analyze volumes of various brain regions with the software "md brain" based on routine MRI scans of 53 pwMS in a real-world setting. We compare brain volumes of pwMS with an EDSS ≥ 3.5 and a disease duration ≥ 10 years to the brain volumes of pwMS with an EDSS < 3.5 and a disease duration < 10 years as well as with or without immunotherapy.

RESULTS

pwMS with an EDSS ≥ 3.5 and a disease duration ≥ 10 years had significantly lower volumes of the total brain, the grey matter and of the frontal, temporal, parietal and occipital lobe regions as compared to pwMS with an EDSS < 3.5 and a disease duration < 10 years. Regional brain volumes were significantly lower in pwMS without immunotherapy.

CONCLUSIONS

The study showed that higher EDSS, longer disease duration and absence of immunotherapy was associated with lower volumes in a number of brain regions. Further real-world studies may include larger patient cohorts in longitudinal analyses.

摘要

背景

多发性硬化症患者(pwMS)大脑中的白质和灰质体积萎缩在疾病早期就会出现,且具有重要的临床意义。在临床试验中,脑萎缩可以通过磁共振成像(MRI)和自动化软件工具进行量化。

方法

在本研究中,我们基于53例pwMS在真实环境中的常规MRI扫描,使用“md brain”软件分析了各个脑区的体积。我们将扩展残疾状态量表(EDSS)≥3.5且病程≥10年的pwMS的脑体积与EDSS<3.5且病程<10年的pwMS的脑体积进行比较,同时也比较了接受或未接受免疫治疗的pwMS的脑体积。

结果

与EDSS<3.5且病程<10年的pwMS相比,EDSS≥3.5且病程≥10年的pwMS的全脑、灰质以及额叶、颞叶、顶叶和枕叶区域的体积显著更低。未接受免疫治疗的pwMS的区域脑体积显著更低。

结论

该研究表明,较高的EDSS、较长的病程和未接受免疫治疗与多个脑区体积较低有关。进一步的真实环境研究可能会在纵向分析中纳入更大的患者队列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/e9e04bb0abbd/42466_2024_339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/847340bed0bd/42466_2024_339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/e0b7fc94e798/42466_2024_339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/77afc28ed349/42466_2024_339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/0f551c6a2491/42466_2024_339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/18fe96f6d3aa/42466_2024_339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/e9e04bb0abbd/42466_2024_339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/847340bed0bd/42466_2024_339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/e0b7fc94e798/42466_2024_339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/77afc28ed349/42466_2024_339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/0f551c6a2491/42466_2024_339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/18fe96f6d3aa/42466_2024_339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/11308334/e9e04bb0abbd/42466_2024_339_Fig6_HTML.jpg

相似文献

1
Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool.使用基于人工智能的软件工具对多发性硬化症患者脑萎缩进行的真实世界分析。
Neurol Res Pract. 2024 Aug 8;6(1):40. doi: 10.1186/s42466-024-00339-y.
2
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.磁共振容积成像测量与同龄 MS 患者残疾的相关性:来自同一年龄队列的描述。
Mult Scler Relat Disord. 2023 Mar;71:104568. doi: 10.1016/j.msard.2023.104568. Epub 2023 Feb 12.
3
Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumes.多发性硬化症的血管疾病危险因素:对代谢和脑容量的影响。
Mult Scler Relat Disord. 2023 Jun;74:104675. doi: 10.1016/j.msard.2023.104675. Epub 2023 Mar 31.
4
Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.原发性进行性多发性硬化症中的脑萎缩与身体残疾:一项容积研究。
Neuroradiol J. 2015 Jun;28(3):354-8. doi: 10.1177/1971400915594984.
5
Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting.短期磁共振成像测量作为复发缓解型多发性硬化症扩展残疾状态量表进展的预测指标:在实际情况中,灰质萎缩而非病灶具有预测性。
PeerJ. 2016 Sep 20;4:e2442. doi: 10.7717/peerj.2442. eCollection 2016.
6
Prognostic value of single-subject grey matter networks in early multiple sclerosis.单个体灰质网络对早期多发性硬化症的预后价值。
Brain. 2024 Jan 4;147(1):135-146. doi: 10.1093/brain/awad288.
7
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach.使用无监督机器学习对多发性硬化症患者进行分层:单次就诊 MRI 驱动方法。
Eur Radiol. 2022 Aug;32(8):5382-5391. doi: 10.1007/s00330-022-08610-z. Epub 2022 Mar 14.
8
The association between MRI brain volumes and computerized cognitive scores of people with multiple sclerosis.多发性硬化症患者的 MRI 脑容量与计算机认知评分的相关性。
Brain Cogn. 2020 Nov;145:105614. doi: 10.1016/j.bandc.2020.105614. Epub 2020 Sep 11.
9
Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.多发性硬化症患者认知障碍的脑容量对应指标
J Neurol Sci. 2009 Jul 15;282(1-2):120-4. doi: 10.1016/j.jns.2008.12.019. Epub 2009 Jan 21.
10
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.在复发缓解型多发性硬化症中,颈髓区域主要与幕下灰质和白质体积相关:一项使用半自动脊髓容积测量法和基于体素的形态测量学的研究
Mult Scler Relat Disord. 2015 May;4(3):264-72. doi: 10.1016/j.msard.2015.04.003. Epub 2015 Apr 15.

本文引用的文献

1
Artificial-intelligence-based MRI brain volumetry in patients with essential tremor and tremor-dominant Parkinson's disease.基于人工智能的原发性震颤和震颤为主型帕金森病患者的脑MRI容积测量
Brain Commun. 2023 Oct 13;5(6):fcad271. doi: 10.1093/braincomms/fcad271. eCollection 2023.
2
Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis.NEDA-4 与多发性硬化症无长期残疾进展的关联及其与 NEDA-3 的比较:系统评价和荟萃分析。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 12;9(6). doi: 10.1212/NXI.0000000000200032. Print 2022 Nov.
3
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.
氯法拉滨片治疗复发性多发性硬化症患者灰质萎缩减少。
Eur J Neurol. 2023 Jan;30(1):179-186. doi: 10.1111/ene.15579. Epub 2022 Oct 11.
4
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.钆基对比剂对多发性硬化症患者自动脑萎缩测量的 FreeSurfer 影响。
Eur Radiol. 2022 May;32(5):3576-3587. doi: 10.1007/s00330-021-08405-8. Epub 2022 Jan 3.
5
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.MAGNIMS 关于在临床实践中使用脑和脊髓萎缩测量的共识建议。
Nat Rev Neurol. 2020 Mar;16(3):171-182. doi: 10.1038/s41582-020-0314-x. Epub 2020 Feb 24.
6
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts.多发性硬化症无疾病活动证据(NEDA)——目标的转变
Ann Indian Acad Neurol. 2019 Jul-Sep;22(3):261-263. doi: 10.4103/aian.AIAN_159_19.
7
Silent progression in disease activity-free relapsing multiple sclerosis.疾病活动无复发缓解型多发性硬化的静息进展。
Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.
8
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?多发性硬化症中的调节性B淋巴细胞和T淋巴细胞:是友还是敌?
Auto Immun Highlights. 2018 Nov 10;9(1):9. doi: 10.1007/s13317-018-0109-x.
9
Replication study of GWAS risk loci in Greek multiple sclerosis patients.GWAS 风险基因座在希腊多发性硬化症患者中的复制研究。
Neurol Sci. 2019 Feb;40(2):253-260. doi: 10.1007/s10072-018-3617-6. Epub 2018 Oct 26.
10
Multiple sclerosis - a review.多发性硬化症——综述。
Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18.